India to Host the Eighteenth Edition of South Asia’s Largest Pharma Event

india-to-hosts-18th-edition-of-south-asias-largest-pharma-event

Organized by Informa Markets in India, the eighteenth edition of CPHI & PMEC India 2025 will take place from November 25–27, 2025, at the India Expo Mart, Greater Noida, Delhi NCR. Known as the “Heart of Pharma,” the event will bring together more than 2,000 exhibitors and over 50,000 industry professionals, buyers, and investors from 120 plus countries.

The edition will showcase the complete pharmaceutical value chain—formulations, APIs, excipients, fine chemicals, packaging, machinery, lab equipment, cleanroom technologies, and contract services—offering unmatched opportunities for B2B networking, business expansion, and market insights.

Industry Growth Sets the Stage for a High-Impact Event

Yogesh Mudras, Managing Director, Informa Markets in India, highlighted, “The Indian pharmaceutical industry has evolved into one of the most dynamic and innovation-driven sectors. It is recognised globally for producing affordable generics and life-saving vaccines. With the Union Budget 2025–26 allocating over ₹5,268 crore to the Department of Pharmaceuticals—a nearly 29% increase—the government’s support for R&D, infrastructure and capacity building strengthens India’s vision of becoming a global pharma innovation hub.” He added that CPHI & PMEC India 2025 will act as a powerful platform for collaboration, knowledge exchange and strategic partnerships shaping the future of the Indian pharmaceutical landscape.

India’s Pharma Market Poised for Rapid Expansion

India’s pharmaceutical market continues its robust growth. Industry projections estimate that the sector will reach USD 130 billion by 2030 and USD 450 billion by 2047, reinforcing India’s position as a global pharmaceutical powerhouse.

The 2025 edition will highlight key focus areas—API self-reliance, sustainability, digitalization and exports—reflecting India’s transition towards innovation-led growth. Exhibitors will showcase advancements in clean manufacturing, ESG compliance and Pharma 4.0 technologies, supporting the needs of a future-ready pharma ecosystem.

Strong International Participation to Boost Collaboration

The event will welcome global exhibitors from China, Italy, Germany, Switzerland, South Korea and several other countries. This will help strengthen cross-border partnerships and expand export opportunities.

Attendees can also look forward to popular marquee events such as:

*Pharma Leaders Roundtable

*Women in Pharma Roundtable

*CPHI Pharma Awards

*Pharma Connect Congress

These sessions will foster policy discussions, leadership insights and innovation-oriented dialogue.

Knowledge-Driven Sessions to Deliver Actionable Insights

Over three days, CPHI & PMEC India 2025 will host a wide range of conferences and leadership dialogues. Key themes will include:

*Business sustainability in a shifting geopolitical environment

*Reimagining innovation and manufacturing for affordable, high-impact medicines

*Enhancing patient centricity beyond GMP compliance

*Achieving sustainability goals in packaging and logistics through green design

These sessions aim to equip industry leaders with strategies for responsible growth, operational resilience and global competitiveness.

Leading Pharma and Machinery Players to Exhibit

Top pharmaceutical companies participating include Dr. Reddy’s Laboratories, Hetero Labs, Oceanic Pharmachem, and Akums Drugs and Pharmaceuticals. Others on the list are Morepen Laboratories, MSN Laboratories, Capsugel Healthcare, Biocon, and Jubilant Ingrevia.

On the machinery and technology side, PMEC India will feature leading companies. These include ACG Pam Pharma Technologies, Cadmach Machinery, Ace Technologies, Parle Global Technologies, Klenzaids, Gansons, Elmach Packages, Shimadzu India and Snowbell Machines.

Strong Backing from Key Industry Associations

This year’s edition is supported by leading organisations such as Pharmexcil, IPEC India, BDMAI, OPPI, FOPE and IPA. Their involvement further strengthens the event’s role as a trusted platform for policy advocacy, industry collaboration and sustainable business growth.

Reinforcing India’s Position as the “Pharmacy of the World”

As per the press release, the event’s global reach and comprehensive exhibit profile stand out. With its strong focus on innovation, CPHI & PMEC India 2025 continues to cement India’s position as the pharmacy of the world. The event will foster meaningful partnerships and encourage strategic investment. It will also help shape the next phase of growth for the Indian pharmaceutical industry.